KAM
Kazazian Asset Management Portfolio holdings
AUM
$82.9M
1-Year Est. Return
52.64%
1 Year Est. Return
+52.64%
AUM
$72.4M
AUM Growth
-$49.6M
(-41%)
Holding
62
Top Buys
| 1 | +$1.28M | |
| 2 | +$722K | |
| 3 | +$395K | |
| 4 |
CRWV
CoreWeave Inc
CRWV
|
+$277K |
| 5 |
Sarepta Therapeutics
SRPT
|
+$257K |
Top Sells
| 1 | +$13.7M | |
| 2 | +$12.5M | |
| 3 | +$10.1M | |
| 4 |
Alibaba
BABA
|
+$5.22M |
| 5 |
Chewy
CHWY
|
+$4.05M |
Sector Composition
| 1 | Communication Services | 33.44% |
| 2 | Consumer Discretionary | 29.2% |
| 3 | Financials | 19.46% |
| 4 | Technology | 8.32% |
| 5 | Industrials | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
BridgeBio Pharma
BBIO
$14.7B
| – | – |
-11,840
|
|
||
52
BILL Holdings
BILL
$4.67B
| – | – |
-5,272
|
|
||
53
Cytokinetics
CYTK
$7.65B
| – | – |
-9,796
|
|
||
54
iShares MSCI Mexico ETF
EWW
$2.04B
| – | – |
-4,168
|
|
||
55
Exelixis
EXEL
$11.8B
| – | – |
-6,650
|
|
||
56
Geron
GERN
$836M
| – | – |
-47,500
|
|
||
57
MacroGenics
MGNX
$109M
| – | – |
-19,236
|
|
||
|
MRUS
58
DELISTED
Merus
MRUS
| – | – |
-6,368
|
|
||
59
Novartis
NVS
$277B
| – | – |
-1,819
|
|
||
60
Okta
OKTA
$15.9B
| – | – |
-3,000
|
|
||
61
Pfizer
PFE
$146B
| – | – |
-18,050
|
|
||
62
Regeneron Pharmaceuticals
REGN
$77B
| – | – |
-560
|
|